Status:
COMPLETED
Blood Pressure and Brain Blood Flow Regulation After Midodrine Administration in Those With Spinal Cord Injury
Lead Sponsor:
University of British Columbia
Conditions:
Orthostatic Intolerance
Eligibility:
All Genders
18-49 years
Brief Summary
This project aims to evaluate the physiological effects of Midodrine administration during orthostatic challenge in those with high level spinal cord injury. Midodrine has been shown to improve orthos...
Eligibility Criteria
Inclusion
- To be included in the study, participants must have sustained a traumatic spinal cord injury within the ages of 18-49 years.
- Also, participants must have an injury level above the 6th thoracic vertebrae and be a non-smoker for a minimum of one year.
Exclusion
- Any participants with a history of cardiovascular disease, pulmonary disease or diabetes mellitus will not be eligible.
- Also, participants will not be eligible to take part in study if they experiences acute distress, or are taking medications known to influence cardiovascular function.
- Patient will be not eligible for the study if he/she has known adverse reaction to Midodrine.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01498809
Start Date
March 1 2012
End Date
November 1 2013
Last Update
October 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GF Strong Hospital and Rehabilitation Centre
Vancouver, British Columbia, Canada, V5Z 2G9